| Year |
Citation |
Score |
| 2023 |
Oropeza E, Seker S, Carrel S, Mazumder A, Lozano D, Jimenez A, VandenHeuvel SN, Noltensmeyer DA, Punturi NB, Lei JT, Lim B, Waltz SE, Raghavan SA, Bainbridge MN, Haricharan S. Molecular portraits of cell cycle checkpoint kinases in cancer evolution, progression, and treatment responsiveness. Science Advances. 9: eadf2860. PMID 37390209 DOI: 10.1126/sciadv.adf2860 |
0.322 |
|
| 2023 |
Hunt BG, Davis JC, Fox LH, Vicente-Muñoz S, Lester C, Wells SI, Waltz SE. RON-augmented cholesterol biosynthesis in breast cancer metastatic progression and recurrence. Oncogene. PMID 37029299 DOI: 10.1038/s41388-023-02688-5 |
0.817 |
|
| 2023 |
Hunt BG, Fox LH, Davis JC, Jones A, Lu Z, Waltz SE. An Introduction and Overview of RON Receptor Tyrosine Kinase Signaling. Genes. 14. PMID 36833444 DOI: 10.3390/genes14020517 |
0.821 |
|
| 2022 |
Vicente-Muñoz S, Hunt BG, Lange TE, Wells SI, Waltz SE. NMR-based metabolomic analysis identifies RON-DEK-β-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival. Plos One. 17: e0274128. PMID 36067206 DOI: 10.1371/journal.pone.0274128 |
0.736 |
|
| 2022 |
Brown NE, Jones A, Hunt BG, Waltz SE. Prostate tumor RON receptor signaling mediates macrophage recruitment to drive androgen deprivation therapy resistance through Gas6-mediated Axl and RON signaling. The Prostate. PMID 35860905 DOI: 10.1002/pros.24416 |
0.81 |
|
| 2022 |
Hunt BG, Jones A, Lester C, Davis JC, Benight NM, Waltz SE. RON () and HGFL () Co-Overexpression Supports Breast Tumorigenesis through Autocrine and Paracrine Cellular Crosstalk. Cancers. 14. PMID 35626096 DOI: 10.3390/cancers14102493 |
0.804 |
|
| 2021 |
Ruiz-Torres SJ, Bourn JR, Benight NM, Hunt BG, Lester C, Waltz SE. Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35. Oncogene. PMID 34743208 DOI: 10.1038/s41388-021-02091-y |
0.827 |
|
| 2021 |
Bourn JR, Ruiz-Torres SJ, Hunt BG, Benight NM, Waltz SE. Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling. Cancer Letters. 503: 75-90. PMID 33508385 DOI: 10.1016/j.canlet.2021.01.019 |
0.826 |
|
| 2021 |
Wicker CA, Hunt BG, Krishnan S, Aziz K, Parajuli S, Palackdharry S, Elaban WR, Wise-Draper TM, Mills GB, Waltz SE, Takiar V. Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models. Cancer Letters. PMID 33450358 DOI: 10.1016/j.canlet.2020.12.038 |
0.736 |
|
| 2020 |
Pease NA, Shephard MS, Sertorio M, Waltz SE, Vinnedge LMP. DEK Expression in Breast Cancer Cells Leads to the Alternative Activation of Tumor Associated Macrophages. Cancers. 12. PMID 32708944 DOI: 10.3390/Cancers12071936 |
0.536 |
|
| 2020 |
Sullivan C, Brown NE, Vasiliauskas J, Pathrose P, Starnes SL, Waltz SE. Prostate Epithelial RON Signaling Promotes M2 Macrophage Activation to Drive Prostate Tumor Growth and Progression. Molecular Cancer Research : McR. PMID 32439702 DOI: 10.1158/1541-7786.MCR-20-0060 |
0.808 |
|
| 2020 |
Hunt BG, Wicker CA, Bourn JR, Lower EE, Takiar V, Waltz SE. MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients. Breast Cancer Research and Treatment. PMID 32342233 DOI: 10.1007/S10549-020-05653-Y |
0.808 |
|
| 2020 |
Wicker CA, Hunt BG, Palackdharry S, Elaban WR, Mills GB, Wise-Draper T, Waltz S, Takiar V. Abstract 6278: Glutaminase inhibition in combination with ionizing radiation improves treatment response in head and neck squamous cell carcinoma models Cancer Research. 80: 6278-6278. DOI: 10.1158/1538-7445.Am2020-6278 |
0.496 |
|
| 2019 |
Babicky ML, Harper MM, Chakedis J, Cazes A, Mose ES, Jaquish DV, French RP, Childers B, Alakus H, Schmid MC, Foubert P, Miyamoto J, Holman PJ, Walterscheid ZJ, Tang CM, ... ... Waltz SE, et al. MST1R kinase accelerates pancreatic cancer progression via effects on both epithelial cells and macrophages. Oncogene. PMID 30967626 DOI: 10.1038/s41388-019-0811-9 |
0.514 |
|
| 2019 |
Ge C, Vilfranc CL, Che L, Pandita RK, Hambarde S, Andreassen PR, Niu L, Olowokure O, Shah S, Waltz SE, Zou L, Wang J, Pandita TK, Du C. The BRUCE-ATR signaling axis is required for accurate DNA replication and suppression of liver cancer development. Hepatology (Baltimore, Md.). PMID 30693543 DOI: 10.1002/Hep.30529 |
0.374 |
|
| 2018 |
Brown NE, Sullivan C, Waltz SE. Therapeutic Considerations for Ron Receptor Expression in Prostate Cancer. Ems Cancer Science Journal. 1. PMID 30775725 |
0.841 |
|
| 2018 |
Modur V, Singh N, Mohanty V, Chung E, Muhammad B, Choi K, Chen X, Chetal K, Ratner N, Salomonis N, Weirauch MT, Waltz S, Huang G, Privette-Vinnedge L, Park JS, et al. Defective transcription elongation in a subset of cancers confers immunotherapy resistance. Nature Communications. 9: 4410. PMID 30353012 DOI: 10.1038/S41467-018-06810-0 |
0.534 |
|
| 2018 |
Brown NE, Paluch AM, Nashu MA, Komurov K, Waltz SE. Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation. Neoplasia (New York, N.Y.). 20: 917-929. PMID 30121008 DOI: 10.1016/j.neo.2018.07.003 |
0.705 |
|
| 2017 |
Zhou Z, Jafari M, Sriram V, Kim J, Lee JY, Ruiz-Torres SJ, Waltz SE. Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy. Molecular Pharmaceutics. PMID 29077410 DOI: 10.1021/Acs.Molpharmaceut.7B00669 |
0.79 |
|
| 2017 |
Ruiz-Torres SJ, Benight NM, Karns RA, Lower EE, Guan JL, Waltz SE. HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling. Oncotarget. 8: 58918-58933. PMID 28938607 DOI: 10.18632/Oncotarget.19441 |
0.841 |
|
| 2017 |
Hunt BG, Wang YL, Chen MS, Wang SC, Waltz SE. Maternal diethylhexyl phthalate exposure affects adiposity and insulin tolerance in offspring in a PCNA-dependent manner. Environmental Research. 159: 588-594. PMID 28915506 DOI: 10.1016/j.envres.2017.09.004 |
0.707 |
|
| 2017 |
Zhou Z, Kennell C, Jafari M, Lee JY, Ruiz-Torres SJ, Waltz SE, Lee JH. Sequential Delivery of Erlotinib and Doxorubicin for Enhanced Triple Negative Breast Cancer Treatment Using Polymeric Nanoparticle. International Journal of Pharmaceutics. PMID 28778627 DOI: 10.1016/J.Ijpharm.2017.07.085 |
0.786 |
|
| 2017 |
Ruiz-Torres SJ, Benight NM, Karns RA, Lower EE, Guan JL, Waltz SE. HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling. Oncotarget. PMID 28753558 DOI: 10.18632/oncotarget.19441 |
0.544 |
|
| 2017 |
Andrade K, Fornetti J, Zhao L, Miller SC, Randall RL, Anderson N, Waltz SE, McHale M, Welm AL. RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis. Science Translational Medicine. 9. PMID 28123075 DOI: 10.1126/Scitranslmed.Aai9338 |
0.404 |
|
| 2017 |
Paul R, Yeo SK, Luo M, Waltz S, Guan J. Abstract 5882: FAK is required for the survival of tumor cells in MMTV-Wnt1 driven basal-like mammary tumors Cancer Research. 77: 5882-5882. DOI: 10.1158/1538-7445.Am2017-5882 |
0.505 |
|
| 2015 |
Johnson AL, Zinser GM, Waltz SE. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity. Oncotarget. 6: 16304-20. PMID 26008979 DOI: 10.18632/Oncotarget.4059 |
0.839 |
|
| 2015 |
Benight NM, Wagh PK, Zinser GM, Peace BE, Stuart WD, Vasiliauskas J, Pathrose P, Starnes SL, Waltz SE. HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses. Oncotarget. 6: 17445-61. PMID 25938541 DOI: 10.18632/Oncotarget.3641 |
0.821 |
|
| 2015 |
Stuart WD, Brown NE, Paluch AM, Waltz SE. Loss of Ron receptor signaling leads to reduced obesity, diabetic phenotypes and hepatic steatosis in response to high-fat diet in mice. American Journal of Physiology. Endocrinology and Metabolism. 308: E562-72. PMID 25648832 DOI: 10.1152/ajpendo.00467.2014 |
0.687 |
|
| 2015 |
Privette Vinnedge LM, Benight NM, Wagh PK, Pease NA, Nashu MA, Serrano-Lopez J, Adams AK, Cancelas JA, Waltz SE, Wells SI. The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers. Oncogene. 34: 2325-36. PMID 24954505 DOI: 10.1038/onc.2014.173 |
0.854 |
|
| 2015 |
Johnson AL, Zinser GM, Waltz SE. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity Oncotarget. 6: 16304-16320. |
0.346 |
|
| 2014 |
Johnson AL, Zinser GM, Waltz SE. Loss of vitamin D receptor signaling from the mammary epithelium or adipose tissue alters pubertal glandular development. American Journal of Physiology. Endocrinology and Metabolism. 307: E674-85. PMID 25139050 DOI: 10.1152/Ajpendo.00200.2014 |
0.807 |
|
| 2014 |
Gurusamy D, Ruiz-Torres SJ, Johnson AL, Smith DA, Waltz SE. Hepatocyte growth factor-like protein is a positive regulator of early mammary gland ductal morphogenesis. Mechanisms of Development. 133: 11-22. PMID 25049204 DOI: 10.1016/J.Mod.2014.07.002 |
0.847 |
|
| 2014 |
Vasiliauskas J, Nashu MA, Pathrose P, Starnes SL, Waltz SE. Hepatocyte growth factor-like protein is required for prostate tumor growth in the TRAMP mouse model. Oncotarget. 5: 5547-58. PMID 24980820 DOI: 10.18632/oncotarget.2139 |
0.833 |
|
| 2014 |
Kulkarni RM, Stuart WD, Waltz SE. Ron receptor-dependent gene regulation of Kupffer cells during endotoxemia. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 13: 281-92. PMID 24919612 DOI: 10.1016/S1499-3872(14)60254-X |
0.783 |
|
| 2014 |
Kulkarni RM, Stuart WD, Gurusamy D, Waltz SE. Ron receptor signaling is protective against DSS-induced colitis in mice. American Journal of Physiology. Gastrointestinal and Liver Physiology. 306: G1065-74. PMID 24742989 DOI: 10.1152/ajpgi.00421.2013 |
0.818 |
|
| 2014 |
Zhao H, Chen MS, Lo YH, Waltz SE, Wang J, Ho PC, Vasiliauskas J, Plattner R, Wang YL, Wang SC. The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer. Oncogene. 33: 1429-37. PMID 23542172 DOI: 10.1038/Onc.2013.84 |
0.459 |
|
| 2013 |
Cai Y, Balli D, Ustiyan V, Fulford L, Hiller A, Misetic V, Zhang Y, Paluch AM, Waltz SE, Kasper S, Kalin TV. Foxm1 expression in prostate epithelial cells is essential for prostate carcinogenesis. The Journal of Biological Chemistry. 288: 22527-41. PMID 23775078 DOI: 10.1074/Jbc.M113.455089 |
0.481 |
|
| 2013 |
Eyob H, Ekiz HA, Derose YS, Waltz SE, Williams MA, Welm AL. Inhibition of ron kinase blocks conversion of micrometastases to overt metastases by boosting antitumor immunity. Cancer Discovery. 3: 751-60. PMID 23612011 DOI: 10.1158/2159-8290.Cd-12-0480 |
0.432 |
|
| 2013 |
Gurusamy D, Gray JK, Pathrose P, Kulkarni RM, Finkleman FD, Waltz SE. Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth. Cancer Research. 73: 1752-63. PMID 23328584 DOI: 10.1158/0008-5472.CAN-12-2474 |
0.836 |
|
| 2012 |
Kulkarni RM, Kutcher LW, Stuart WD, Carson DJ, Leonis MA, Waltz SE. Ron receptor-dependent gene regulation in a mouse model of endotoxin-induced acute liver failure. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 11: 383-92. PMID 22893465 DOI: 10.1016/S1499-3872(12)60196-9 |
0.799 |
|
| 2012 |
Benight NM, Waltz SE. Ron receptor tyrosine kinase signaling as a therapeutic target. Expert Opinion On Therapeutic Targets. 16: 921-31. PMID 22834780 DOI: 10.1517/14728222.2012.710200 |
0.825 |
|
| 2012 |
Huitema LF, Renn J, Logister I, Gray JK, Waltz SE, Flik G, Schulte-Merker S. Macrophage-stimulating protein and calcium homeostasis in zebrafish. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 4092-101. PMID 22787265 DOI: 10.1096/fj.11-202663 |
0.297 |
|
| 2012 |
Wagh PK, Zinser GM, Gray JK, Shrestha A, Waltz SE. Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis. Endocrinology. 153: 2735-46. PMID 22474186 DOI: 10.1210/En.2011-1543 |
0.859 |
|
| 2012 |
Marshall AM, McClaine RJ, Gurusamy D, Gray JK, Lewnard KE, Khan SA, Waltz SE. Estrogen receptor alpha deletion enhances the metastatic phenotype of Ron overexpressing mammary tumors in mice. Molecular Cancer. 11: 2. PMID 22226043 DOI: 10.1186/1476-4598-11-2 |
0.85 |
|
| 2011 |
Thobe MN, Gray JK, Gurusamy D, Paluch AM, Wagh PK, Pathrose P, Lentsch AB, Waltz SE. The Ron receptor promotes prostate tumor growth in the TRAMP mouse model. Oncogene. 30: 4990-8. PMID 21625214 DOI: 10.1038/Onc.2011.205 |
0.818 |
|
| 2011 |
Stuart WD, Kulkarni RM, Gray JK, Vasiliauskas J, Leonis MA, Waltz SE. Ron receptor regulates Kupffer cell-dependent cytokine production and hepatocyte survival following endotoxin exposure in mice. Hepatology (Baltimore, Md.). 53: 1618-28. PMID 21520175 DOI: 10.1002/hep.24239 |
0.809 |
|
| 2011 |
Wagh PK, Gray JK, Zinser GM, Vasiliauskas J, James L, Monga SP, Waltz SE. β-Catenin is required for Ron receptor-induced mammary tumorigenesis. Oncogene. 30: 3694-704. PMID 21423209 DOI: 10.1038/Onc.2011.86 |
0.857 |
|
| 2011 |
Privette Vinnedge LM, McClaine R, Wagh PK, Wikenheiser-Brokamp KA, Waltz SE, Wells SI. The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer. Oncogene. 30: 2741-52. PMID 21317931 DOI: 10.1038/Onc.2011.2 |
0.842 |
|
| 2011 |
Welsh J, Zinser LN, Mianecki-Morton L, Martin J, Waltz SE, James H, Zinser GM. Age-related changes in the epithelial and stromal compartments of the mammary gland in normocalcemic mice lacking the vitamin D3 receptor. Plos One. 6: e16479. PMID 21298063 DOI: 10.1371/Journal.Pone.0016479 |
0.812 |
|
| 2011 |
Zhao H, Lo YH, Ma L, Waltz SE, Gray JK, Hung MC, Wang SC. Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growth. Molecular Cancer Therapeutics. 10: 29-36. PMID 21220489 DOI: 10.1158/1535-7163.MCT-10-0778 |
0.47 |
|
| 2011 |
Nikolaidis NM, Kulkarni RM, Gray JK, Collins MH, Waltz SE. Ron receptor deficient alveolar myeloid cells exacerbate LPS-induced acute lung injury in the murine lung. Innate Immunity. 17: 499-507. PMID 21088048 DOI: 10.1177/1753425910383725 |
0.814 |
|
| 2011 |
Kretschmann* K, Waltz S, Welm A. The role of macrophage stimulating protein in metastasis of breast cancer to bone Bone. 48: S18. DOI: 10.1016/j.bone.2010.10.046 |
0.389 |
|
| 2010 |
McClaine RJ, Marshall AM, Wagh PK, Waltz SE. Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines. Neoplasia (New York, N.Y.). 12: 650-8. PMID 20689759 DOI: 10.1593/Neo.10476 |
0.845 |
|
| 2010 |
Meyer SE, Peace BE, Bahassi el M, Kavanaugh GM, Wagh PK, Robbins SB, Yin M, Wells SI, Zinser GM, Stambrook PJ, Waltz SE. Chk2*1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in mice. Cancer Letters. 296: 186-93. PMID 20434834 DOI: 10.1016/J.Canlet.2010.04.011 |
0.841 |
|
| 2010 |
Jiang P, Hu Q, Ito M, Meyer S, Waltz S, Khan S, Roeder RG, Zhang X. Key roles for MED1 LxxLL motifs in pubertal mammary gland development and luminal-cell differentiation. Proceedings of the National Academy of Sciences of the United States of America. 107: 6765-70. PMID 20351249 DOI: 10.1073/Pnas.1001814107 |
0.706 |
|
| 2010 |
Zhao H, Ou-Yang F, Chen IF, Hou MF, Yuan SS, Chang HL, Lee YC, Plattner R, Waltz SE, Ho SM, Sims J, Wang SC. Enhanced resistance to tamoxifen by the c-ABL proto-oncogene in breast cancer. Neoplasia (New York, N.Y.). 12: 214-23. PMID 20234815 DOI: 10.1593/Neo.91576 |
0.665 |
|
| 2010 |
Logan-Collins J, Thomas RM, Yu P, Jaquish D, Mose E, French R, Stuart W, McClaine R, Aronow B, Hoffman RM, Waltz SE, Lowy AM. Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers. Cancer Research. 70: 1130-40. PMID 20103639 DOI: 10.1158/0008-5472.Can-09-0761 |
0.822 |
|
| 2010 |
Thobe MN, Gurusamy D, Pathrose P, Waltz SE. The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells. Oncogene. 29: 214-26. PMID 19838218 DOI: 10.1038/Onc.2009.331 |
0.828 |
|
| 2010 |
Nikolaidis NM, Gray JK, Gurusamy D, Fox W, Stuart WD, Huber N, Waltz SE. Ron receptor tyrosine kinase negatively regulates TNFalpha production in alveolar macrophages by inhibiting NF-kappaB activity and Adam17 production. Shock (Augusta, Ga.). 33: 197-204. PMID 19487969 DOI: 10.1097/SHK.0b013e3181ae8155 |
0.82 |
|
| 2010 |
Zhao HJ, Ou-Yang F, Chen I, Hou M, Yuan SF, Chang H, Lee Y, Plattner R, Waltz S, Ho S, Sims J, Wang S. Abstract LB-179: Enhanced resistance to tamoxifen by the c-ABL proto-oncogene in breast cancer Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-179 |
0.616 |
|
| 2009 |
Meyer SE, Zinser GM, Stuart WD, Pathrose P, Waltz SE. The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis. Developmental Biology. 333: 173-85. PMID 19576199 DOI: 10.1016/J.Ydbio.2009.06.028 |
0.852 |
|
| 2009 |
Meyer SE, Waltz SE, Goss KH. The Ron receptor tyrosine kinase is not required for adenoma formation in Apc(Min/+) mice. Molecular Carcinogenesis. 48: 995-1004. PMID 19452510 DOI: 10.1002/mc.20551 |
0.698 |
|
| 2009 |
McClaine R, Waltz S. 43: Activation of Ron Receptor Leads to ERα-Positive Mammary Tumors and Confers Resistance to Tamoxifen Journal of Surgical Research. 151: 191. DOI: 10.1016/j.jss.2008.11.070 |
0.42 |
|
| 2008 |
Wagh PK, Peace BE, Waltz SE. Met-related receptor tyrosine kinase Ron in tumor growth and metastasis. Advances in Cancer Research. 100: 1-33. PMID 18620091 DOI: 10.1016/S0065-230X(08)00001-8 |
0.844 |
|
| 2008 |
Caldwell CC, Martignoni A, Leonis MA, Ondiveeran HK, Fox-Robichaud AE, Waltz SE. Ron receptor tyrosine kinase-dependent hepatic neutrophil recruitment and survival benefit in a murine model of bacterial peritonitis. Critical Care Medicine. 36: 1585-93. PMID 18434891 DOI: 10.1097/CCM.0b013e318170a8c2 |
0.79 |
|
| 2008 |
Logan-Collins J, Lowy A, Stuart W, Waltz S. shRNA silencing of the RON receptor tyrosine kinase results in increased sensitivity to gemcitabine in pancreatic subcutaneous xenograft tumors Journal of the American College of Surgeons. 207: S98. DOI: 10.1016/J.Jamcollsurg.2008.06.248 |
0.517 |
|
| 2007 |
Leonis MA, Thobe MN, Waltz SE. Ron-receptor tyrosine kinase in tumorigenesis and metastasis. Future Oncology (London, England). 3: 441-8. PMID 17661719 DOI: 10.2217/14796694.3.4.441 |
0.837 |
|
| 2007 |
Thomas RM, Toney K, Fenoglio-Preiser C, Revelo-Penafiel MP, Hingorani SR, Tuveson DA, Waltz SE, Lowy AM. The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression. Cancer Research. 67: 6075-82. PMID 17616662 DOI: 10.1158/0008-5472.Can-06-4128 |
0.482 |
|
| 2007 |
Lentsch AB, Pathrose P, Kader S, Kuboki S, Collins MH, Waltz SE. The Ron receptor tyrosine kinase regulates acute lung injury and suppresses nuclear factor kappaB activation. Shock (Augusta, Ga.). 27: 274-80. PMID 17304108 DOI: 10.1097/01.shk.0000239755.82711.89 |
0.408 |
|
| 2007 |
Chan EL, Peace BE, Toney K, Kader SA, Pathrose P, Collins MH, Waltz SE. Homozygous K5Cre transgenic mice have wavy hair and accelerated malignant progression in a murine model of skin carcinogenesis. Molecular Carcinogenesis. 46: 49-59. PMID 17013830 DOI: 10.1002/mc.20192 |
0.795 |
|
| 2007 |
Wetzel CC, Leonis MA, Dent A, Olson MA, Longmeier AM, Ney PA, Boivin GP, Kader SA, Caldwell CC, Degen SJ, Waltz SE. Short-form Ron receptor is required for normal IFN-gamma production in concanavalin A-induced acute liver injury. American Journal of Physiology. Gastrointestinal and Liver Physiology. 292: G253-61. PMID 17008558 DOI: 10.1152/ajpgi.00134.2006 |
0.833 |
|
| 2006 |
Zinser GM, Leonis MA, Toney K, Pathrose P, Thobe M, Kader SA, Peace BE, Beauman SR, Collins MH, Waltz SE. Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation. Cancer Research. 66: 11967-74. PMID 17178895 DOI: 10.1158/0008-5472.Can-06-2473 |
0.835 |
|
| 2006 |
O'Toole JM, Rabenau KE, Burns K, Lu D, Mangalampalli V, Balderes P, Covino N, Bassi R, Prewett M, Gottfredsen KJ, Thobe MN, Cheng Y, Li Y, Hicklin DJ, Zhu Z, ... Waltz SE, et al. Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member. Cancer Research. 66: 9162-70. PMID 16982759 DOI: 10.1158/0008-5472.Can-06-0283 |
0.842 |
|
| 2006 |
Shen H, Schuster R, Lu B, Waltz SE, Lentsch AB. Critical and opposing roles of the chemokine receptors CXCR2 and CXCR3 in prostate tumor growth. The Prostate. 66: 1721-8. PMID 16941672 DOI: 10.1002/pros.20476 |
0.479 |
|
| 2006 |
Shen H, Schuster R, Stringer KF, Waltz SE, Lentsch AB. The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 59-64. PMID 16394268 DOI: 10.1096/fj.05-4764com |
0.477 |
|
| 2006 |
Mallakin A, Kutcher LW, McDowell SA, Kong S, Schuster R, Lentsch AB, Aronow BJ, Leikauf GD, Waltz SE. Gene expression profiles of Mst1r-deficient mice during nickel-induced acute lung injury. American Journal of Respiratory Cell and Molecular Biology. 34: 15-27. PMID 16166746 DOI: 10.1165/Rcmb.2005-0093Oc |
0.806 |
|
| 2006 |
Martignoni A, Caldwell C, Kader S, Toney K, Goetzmann H, Waltz S. RON RECEPTOR SIGNALING ENHANCES SURVIVAL DURING INFECTIONS BY STIMULATING MACROPHAGE-DEPENDENT PRO-INFLAMMATORY MEDIATOR PRODUCTION Shock. 25: 31. DOI: 10.1097/00024382-200606001-00093 |
0.436 |
|
| 2005 |
Tsutsui S, Noorbakhsh F, Sullivan A, Henderson AJ, Warren K, Toney-Earley K, Waltz SE, Power C. RON-regulated innate immunity is protective in an animal model of multiple sclerosis. Annals of Neurology. 57: 883-95. PMID 15929040 DOI: 10.1002/Ana.20502 |
0.353 |
|
| 2005 |
Peace BE, Toney-Earley K, Collins MH, Waltz SE. Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer. Cancer Research. 65: 1285-93. PMID 15735014 DOI: 10.1158/0008-5472.CAN-03-3580 |
0.868 |
|
| 2005 |
Chan EL, Peace BE, Collins MH, Toney-Earley K, Waltz SE. Ron tyrosine kinase receptor regulates papilloma growth and malignant conversion in a murine model of skin carcinogenesis. Oncogene. 24: 479-88. PMID 15531916 DOI: 10.1038/sj.onc.1208231 |
0.827 |
|
| 2004 |
van den Akker E, van Dijk T, Parren-van Amelsvoort M, Grossmann KS, Schaeper U, Toney-Earley K, Waltz SE, Löwenberg B, von Lindern M. Tyrosine kinase receptor RON functions downstream of the erythropoietin receptor to induce expansion of erythroid progenitors. Blood. 103: 4457-65. PMID 14982882 DOI: 10.1182/blood-2003-08-2713 |
0.415 |
|
| 2003 |
Hess KA, Waltz SE, Toney-Earley K, Degen SJ. The receptor tyrosine kinase Ron is expressed in the mouse ovary and regulates inducible nitric oxide synthase levels and ovulation. Fertility and Sterility. 80: 747-54. PMID 14505749 DOI: 10.1016/S0015-0282(03)00774-X |
0.705 |
|
| 2003 |
Peace BE, Hill KJ, Degen SJ, Waltz SE. Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor. Experimental Cell Research. 289: 317-25. PMID 14499632 DOI: 10.1016/S0014-4827(03)00280-5 |
0.809 |
|
| 2003 |
Wetzel CC, Degen SJ, Waltz SE. Cis-acting elements in the hepatocyte growth factor-like protein gene regulate kidney and liver-specific expression in mice. Dna and Cell Biology. 22: 293-301. PMID 12941157 DOI: 10.1089/104454903322216644 |
0.679 |
|
| 2003 |
Hess KA, Waltz SE, Chan EL, Degen SJ. Receptor tyrosine kinase Ron is expressed in mouse reproductive tissues during embryo implantation and is important in trophoblast cell function. Biology of Reproduction. 68: 1267-75. PMID 12606483 DOI: 10.1095/biolreprod.102.009928 |
0.74 |
|
| 2002 |
Leonis MA, Toney-Earley K, Degen SJ, Waltz SE. Deletion of the Ron receptor tyrosine kinase domain in mice provides protection from endotoxin-induced acute liver failure. Hepatology (Baltimore, Md.). 36: 1053-60. PMID 12395314 DOI: 10.1053/jhep.2002.36822 |
0.809 |
|
| 2002 |
McDowell SA, Mallakin A, Bachurski CJ, Toney-Earley K, Prows DR, Bruno T, Kaestner KH, Witte DP, Melin-Aldana H, Degen SJ, Leikauf GD, Waltz SE. The role of the receptor tyrosine kinase Ron in nickel-induced acute lung injury. American Journal of Respiratory Cell and Molecular Biology. 26: 99-104. PMID 11751209 DOI: 10.1165/Ajrcmb.26.1.4621 |
0.709 |
|
| 2001 |
Peace BE, Hughes MJ, Degen SJ, Waltz SE. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis. Oncogene. 20: 6142-51. PMID 11593422 DOI: 10.1038/sj.onc.1204836 |
0.734 |
|
| 2001 |
Waltz SE, Eaton L, Toney-Earley K, Hess KA, Peace BE, Ihlendorf JR, Wang MH, Kaestner KH, Degen SJ. Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses. The Journal of Clinical Investigation. 108: 567-76. PMID 11518730 DOI: 10.1172/Jci11881 |
0.715 |
|
| 2001 |
Leonis MA, Waltz SE, Degen SJ. The role of the RON receptor tyrosine kinase in a murine model of fulminant hepatic failure Gastroenterology. 120: A28. DOI: 10.1016/S0016-5085(08)80136-9 |
0.676 |
|
| 1999 |
Muraoka RS, Waltz SE, Degen SJ. Expression of Hepatocyte Growth Factor-Like Protein Is Repressed by Retinoic Acid and Enhanced by Cyclic Adenosine 3',5'-Monophosphate Response Element-Binding Protein (CREB)-Binding Protein (CBP)* *This work was supported in part by USPHS Grant DK-47003 from the NIDDK, NIH (to S.J.F.D.), NIH Training Grant HL-07527 (to R.S.M.), National Research Scientist Award Postdoctoral Fellowship (to S.E.W.), and a Board of Trustees Fellowship from the Children's Hospital Research Foundation (to S.E.W.). Endocrinology. 140: 187-196. PMID 28200799 DOI: 10.1210/endo.140.1.6441 |
0.621 |
|
| 1999 |
Muraoka RS, Sun WY, Colbert MC, Waltz SE, Witte DP, Degen JL, Degen SJF. The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse Journal of Clinical Investigation. 103: 1277-1285. PMID 10225971 DOI: 10.1172/Jci6091 |
0.443 |
|
| 1999 |
Muraoka RS, Waltz SE, Degen SJ. Expression of hepatocyte growth factor-like protein is repressed by retinoic acid and enhanced by cyclic adenosine 3',5'-monophosphate response element-binding protein (CREB)-binding protein (CBP). Endocrinology. 140: 187-96. PMID 9886825 DOI: 10.1210/endo.140.1.6441 |
0.663 |
|
| 1998 |
Degen SJ, McDowell SA, Waltz SE, Gould F, Stuart LA, Carritt B. Structure of the human D1F15S1A locus: a chromosome 1 locus with 97% identity to the chromosome 3 gene coding for hepatocyte growth factor-like protein. Dna Sequence : the Journal of Dna Sequencing and Mapping. 8: 409-13. PMID 10728827 DOI: 10.3109/10425179809020903 |
0.631 |
|
| 1998 |
Waltz SE, Toms CL, McDowell SA, Clay LA, Muraoka RS, Air EL, Sun WY, Thomas MB, Degen SJ. Characterization of the mouse Ron/Stk receptor tyrosine kinase gene. Oncogene. 16: 27-42. PMID 9467940 DOI: 10.1038/Sj.Onc.1201508 |
0.655 |
|
| 1997 |
Waltz SE, McDowell SA, Muraoka RS, Air EL, Flick LM, Chen YQ, Wang MH, Degen SJ. Functional characterization of domains contained in hepatocyte growth factor-like protein. The Journal of Biological Chemistry. 272: 30526-37. PMID 9374547 DOI: 10.1074/Jbc.272.48.30526 |
0.654 |
|
| 1996 |
Waltz SE, Trivedi AA, Leffak M. DNA replication initiates non-randomly at multiple sites near the c-myc gene in HeLa cells Nucleic Acids Research. 24: 1887-1894. PMID 8657570 DOI: 10.1093/Nar/24.10.1887 |
0.619 |
|
| 1996 |
Waltz SE, Gould FK, Air EL, McDowell SA, Degen SJ. Hepatocyte nuclear factor-4 is responsible for the liver-specific expression of the gene coding for hepatocyte growth factor-like protein. The Journal of Biological Chemistry. 271: 9024-32. PMID 8621550 DOI: 10.1074/Jbc.271.15.9024 |
0.672 |
|
| 1995 |
McWhinney C, Waltz SE, Leffak M. Cis-acting effects of sequences within 2.4-kb upstream of the human c-myc gene on autonomous plasmid replication in HeLa cells Dna and Cell Biology. 14: 565-579. PMID 7626216 DOI: 10.1089/Dna.1995.14.565 |
0.625 |
|
| Show low-probability matches. |